1. Home
  2. SPRU vs LUNG Comparison

SPRU vs LUNG Comparison

Compare SPRU & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$2.91

Market Cap

52.2M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.66

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRU
LUNG
Founded
2008
1995
Country
United States
United States
Employees
4
N/A
Industry
Auto Parts:O.E.M.
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
57.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
SPRU
LUNG
Price
$2.91
$1.66
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
46.5K
501.7K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
62.30
7.64
EPS
N/A
N/A
Revenue
$23,194,000.00
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
48.68
8.01
52 Week Low
$1.13
$1.13
52 Week High
$6.75
$3.88

Technical Indicators

Market Signals
Indicator
SPRU
LUNG
Relative Strength Index (RSI) 37.35 68.55
Support Level $2.56 $1.51
Resistance Level $3.32 $1.93
Average True Range (ATR) 0.23 0.10
MACD 0.01 0.04
Stochastic Oscillator 27.20 89.90

Price Performance

Historical Comparison
SPRU
LUNG

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: